Philippines FDA: List of registrable IVDs - guidelines for comments

Philippines FDA: List of registrable IVDs – draft guidelines for comments

The Philippines Food and Drug Administration (FDA) is seeking comments from IVD manufacturers and distributors (importers/exporters/wholesalers) on draft guidelines entitled “Specific list of registrable IVD medical devices and revised technical requirements for registration of COVID-19 test kits”.

The draft FDA Circular provides a specific list of registrable IVDs including the addition of COVID-19 test kits. It also provides guidelines on the transition from the issuance of Special Certification to Certificate of Product Registration (CPR) for COVID-19 test kits as well as the revised requirements for COVID-19 test kits registration.

Summary of the guidelines:

a) The following IVDs are on the list of registrable IVDs that require performance evaluation. For the full list, please refer to this link: https://www.fda.gov.ph/draft-for-comments-specific-list-of-registrable-in-vitro-diagnostic-medical-devices-ivds-and-revised-technical-requirements-for-registration-of-covid-19-test-kits/

IVD Medical Device

Laboratory performing the evaluation test

1.     Pregnancy Test Kits using urine specimen

FDA Common Services laboratory (FDA CSL)

2.     HIV (Antibody, antigen)

HBV (Antibody, antigen) including Hepatitis markers (Antibody, antigen)

HCV (Antibody, antigen)

Syphilis (Treponemal, non-treponemal

CD4**

San Lazaro Hospital- STD AIDS Cooperative Central Laboratory (SACCL)

3.     Shabu/MET

Marijuana/THC

Amphetamine**

Cocaine/Benzoylecgonine

Ecstasy/MDMA

Opiates (Morphine/Codeine)

Benzodiazepine (Nordiazepam/Oxazepam)

East Avenue Medical Center (EAMC)

4.     Anti-A reagents (blood typing sera)

Anti-B reagents (blood typing sera)

Anti-D/Rh reagents

Known cells or reverse cells

Anti-human globulin (AHG) reagents

Potentiators

Antibody screen reagents

Antibody Identification reagents

Phenotyping reagents

Miscellaneous Reagents (Ex. crossmatching reagents)

National Kidney and transplant Institute (NKTI)

5.     COVID-19 test kits and reagents**

Research Institute for Tropical Medicine (RITM)

Notes: ** signifies an IVD that has been added to the list.

b) Leptospirosis test kits/reagents and pregnancy test kits/reagents using specimens other than urine shall not undergo performance evaluation by the NRL. However, the FDA will carry out a review of the technical documentary requirements.

c) All registrable IVDs including COVID-19 test kits shall comply with FDA technical requirements for registration of IVDs as outlined in Annex A of the draft guidelines.

d) The validity of the CPR for COVID-19 test kits is the same as the existing validity of CPR for registrable IVDs.

e) Registration fee for COVID-19 test kits are as follows:

  • Php 1,000 + 1% Legal Research Fee (LRF) for an initial one (1) year validity
  • Php 5,000 + 1% Legal Research Fee (LRF) for renewals having five (5) years validity.

f) The transition period to full CPR for COVID-19 test kits is as follows:

  • COVID-19 test kits with pending initial application and re-issuance application of Special Certification prior to the effectivity of the Circular will still be issued a Special Certification for approved applications. However, once the validity of the issued/ re-issued Special Certification expires, a CPR shall be required.
  • COVID-19 test kits with a valid Special Certification prior to the effectivity of this Circular, must apply for a CPR once the Special Certification expires. The marketing authorization holder may apply for the CPR six (6) months prior to the expiration of the Special Certification.

 

To submit comments:

If you wish to comment or understand more about this draft regulation, please contact your designated Regulatory Affairs Specialist at Andaman Medical. You may also submit your comments directly to cdrrhr-prsdd@fda.gov.ph. The deadline for submission of comments is Friday 4 March 2022.

 

More information:

The full draft of this regulation and its annexes can be accessed at: https://www.fda.gov.ph/draft-for-comments-specific-list-of-registrable-in-vitro-diagnostic-medical-devices-ivds-and-revised-technical-requirements-for-registration-of-covid-19-test-kits/

Learn about the Performance Requirements for Covid-19 Test Kits in the Philippines.

Learn about the Process for Covid-19 Test Kit Applications.  

To learn more about registering medical devices in the Philippines click here.

To learn more about the medical device market in the Philippines click here.

We can register and import your medical device into the Philippines. Contact our sales team to find out more by clicking on the button below.

Sign up for our regulatory roundup delivered once a month to your inbox



Scroll to Top

Contact Us